Basis: FMP quote market capitalization / book value attributable to common shareholders (matching reported total stockholders equity minus preferred stock). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the P/B ratio high or low?
The P/B ratio of 2.02 is 23% below its estimated 1-year average of 2.62, near the low end of its estimated 1-year range (1.93–3.97).
As of 2026-10-06T18:30:58.508Z.
Calculation as of: 2026-10-06T18:30:58.508Z.
Quote observation: 2026-10-06T18:30:06.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 7e5dd7cae71be814523bfc9444594aa14e5919ebae0d9bfc7936539f469f7652
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PB RATIO
2.02
PB RATIO AVG TTM
N/A
PB RATIO AVG 3Y
N/A
PB RATIO AVG 5Y
N/A
PB RATIO AVG 10Y
N/A
PB RATIO AVG 15Y
N/A
PB RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.38
median of 761 covered companies
CURRENT VS SECTOR MEDIAN
-15.13%
vs the sector median at left
| NAME | MARKET CAP | PB RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cerenome, Inc. (CNSY) | $11.05M | 2.02 | N/A | N/A | N/A |
| BioVie Inc. (BIVI)vs › | $11.01M | 1.07 | 0.75 | 2.26 | 6.44 |
| Lisata Therapeutics, Inc. (LSTA)vs › | $11.06M | 1.34 | 1.87 | 1.06 | 0.78 |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.12M | 0.66 | 0.61 | 1.64 | 2.43 |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $11.16M | N/A | 0.83 | 1.30 | 2.83 |
| Caring Brands, Inc. (CABR)vs › | $11.00M | N/A | N/A | N/A | N/A |
| VistaGen Therapeutics, Inc. (VTGN)vs › | $11.29M | 0.46 | 0.82 | 1.08 | 1.67 |
| Lifeward Ltd. (LFWD)vs › | $10.26M | 0.84 | 1.19 | 0.89 | 0.83 |
| Pluri Inc. (PLUR)vs › | $10.59M | N/A | 86.41 | 19.15 | 12.74 |
| Senti Biosciences, Inc. (SNTI)vs › | $10.58M | N/A | 4.71 | 2.07 | 1.62 |
At 2.02, P/B is below its estimated 1-year median — higher than 6% of readings in its estimated 1-year history.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
estimated 1-year low
1.93
median
2.31
estimated 1-year high
3.97
P/B Ratio
2.02
Market Price / Book Value per Share
PB Ratio = Market Cap / (Total Shareholders' Equity − Preferred Stock)
The price-to-book ratio compares market capitalization to book value attributable to common shareholders (total equity minus preferred stock). Lower values can indicate a cheaper valuation relative to net assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PB RATIO |
|---|---|
| 2026-10-05 | 1.93 |
| 2026-10-02 | 1.98 |
| 2026-10-01 | 2.21 |
| 2026-09-30 | 2.32 |
| 2026-09-29 | 2.31 |
| 2026-09-28 | 2.50 |
| 2026-09-25 | 2.47 |
| 2026-09-24 | 2.32 |
| 2026-09-23 | 2.42 |
| 2026-09-22 | 2.52 |
| 2026-09-21 | 2.36 |
| 2026-09-18 | 2.52 |
| 2026-09-17 | 2.52 |
| 2026-09-16 | 2.53 |
| 2026-09-15 | 2.63 |
| 2026-09-14 | 2.69 |
| 2026-09-11 | 2.89 |
| 2026-09-10 | 2.96 |
| 2026-09-09 | 3.09 |
| 2026-09-08 | 3.35 |
| 2026-09-04 | 3.42 |
| 2026-09-03 | 3.69 |
| 2026-09-02 | 3.65 |
| 2026-09-01 | 3.36 |
| 2026-08-31 | 3.50 |
| 2026-08-28 | 3.78 |
| 2026-08-27 | 3.84 |
| 2026-08-26 | 3.74 |
| 2026-08-25 | 3.83 |
| 2026-08-24 | 3.67 |
| 2026-08-21 | 3.81 |
| 2026-08-20 | 3.72 |
| 2026-08-19 | 3.96 |
| 2026-08-18 | 3.82 |
| 2026-08-17 | 3.97 |
| 2026-08-14 | 2.04 |
| 2026-08-13 | 2.06 |
| 2026-08-12 | 2.06 |
| 2026-08-11 | 2.13 |
| 2026-08-10 | 2.13 |
| 2026-08-07 | 2.13 |
| 2026-08-06 | 2.14 |
| 2026-08-05 | 2.17 |
| 2026-08-04 | 2.20 |
| 2026-08-03 | 1.96 |
| 2026-08-02 | 2.13 |
| 2026-07-31 | 2.15 |
| 2026-07-30 | 2.03 |
| 2026-07-29 | 2.02 |
| 2026-07-28 | 2.09 |
| 2026-07-27 | 2.07 |
| 2026-07-24 | 2.13 |
| 2026-07-23 | 2.10 |
| 2026-07-22 | 2.12 |
| 2026-07-21 | 2.18 |
| 2026-07-20 | 2.13 |
| 2026-07-17 | 2.08 |
| 2026-07-16 | 2.17 |
| 2026-07-15 | 2.27 |
| 2026-07-14 | 2.38 |
| 2026-07-13 | 2.32 |
| 2026-07-10 | 2.22 |
| 2026-07-09 | 2.22 |
| 2026-07-08 | 2.12 |
| 2026-07-07 | 2.18 |
| 2026-07-06 | 2.25 |